Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$527.67 +1.48 (+0.28%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Other Non-Current Assets (2009 - 2026)

Updated

Vertex Pharmaceuticals (VRTX) reported Other Non-Current Assets of $1.25 billion for Q2 2026, up 16.0% from $1.08 billion a year earlier but down 0.4% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Other Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Vertex Pharmaceuticals posted Other Non-Current Assets of $1.24 billion, up 23.7% from FY2024.

  • Other Non-Current Assets has increased for five consecutive years, with a five-year compound annual growth rate of 90.5% (FY2020 to FY2025).
  • By year, Other Non-Current Assets came in at $999.3 million in FY2024 (+11.6%), $895.3 million in FY2023 (+118.6%), $409.6 million in FY2022 (+269.7%) and $110.8 million in FY2021 (+124.7%).
  • Five-year quarterly Other Non-Current Assets spans a low of $75.52 million in Q3 2021 and a high of $1.26 billion in Q1 2026.
  • Year over year, Other Non-Current Assets has now increased in each of the last 19 quarters, with growth averaging 28.5% over the last eight quarters.
  • The high point for year-over-year Other Non-Current Assets in five years was Q1 2023 (growth of 286.2%); the low point was Q3 2021 (a decline of 79.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.26 billion (Q1 2026), $1.24 billion (Q4 2025) and $1.1 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 14.27 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 10.73 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 4.75 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 1.25 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 6.38 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.25 Bn
Mar 31, 2026 1.26 Bn
Dec 31, 2025 1.24 Bn
Sep 30, 2025 1.10 Bn
Jun 30, 2025 1.08 Bn
Mar 31, 2025 1.01 Bn
Dec 31, 2024 999.30 Mn
Sep 30, 2024 990.20 Mn
Jun 30, 2024 915.60 Mn
Mar 31, 2024 875.70 Mn
Dec 31, 2023 895.30 Mn
Sep 30, 2023 475.20 Mn
Jun 30, 2023 442.70 Mn
Mar 31, 2023 427.50 Mn
Dec 31, 2022 409.60 Mn
Sep 30, 2022 132.50 Mn
Jun 30, 2022 127.30 Mn
Mar 31, 2022 110.70 Mn
Dec 31, 2021 110.80 Mn
Sep 30, 2021 75.52 Mn
API Access

Vertex Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=VRTX&period=max&api_key=YOUR_API_KEY